Physician

Elvira Usinowicz, APN,C.

According to 2025 Medicare claims, Elvira Usinowicz, APN, C. (NPI: 1427328277) practices certified clinical nurse specialist in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is VALLEY PHYSICIAN SERVICES PC (NPI: 1467815928; TIN: 465285330) and primary practice location at 07652-3619. Usinowicz is affiliated with the ColigoCare, LLC (ACO ID: A3591), participating under the MSSP model.

Usinowicz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 298 traditional Medicare patients, billed 884 HCPCS/CPT codes, and received $63,909 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,049 prescription claims across 203 beneficiaries totaling $1,149,463 in drug costs, led by Vyndamax (Tafamidis). 2022 DME data shows 109 claims. Open Payments data shows 19 records totaling $699. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $23,396 to $63,909. Similarly, Part D prescription costs have moved sharply higher in recent years, from $10,719 to $1,149,463. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	134	463	$23,396
2016	182	666	$43,391
2017	205	640	$47,918
2018	236	714	$55,035
2019	231	722	$55,744
2020	206	521	$39,407
2021	204	548	$52,976
2022	250	610	$50,836
2023	295	689	$53,115
2024	298	884	$63,909

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	61	267	$10,719
2016	94	563	$32,272
2017	131	749	$38,341
2018	162	953	$63,328
2019	147	813	$76,450
2020	162	995	$84,863
2021	179	1,003	$304,398
2022	164	792	$159,732
2023	171	777	$502,741
2024	203	1,049	$1,149,463

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	137	$6,870
2022	N/R	109	$3,931
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	229	470	$105
99221	Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes	24	24	$56
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	51	86	$37
93264	Remote monitoring of pulmonary artery pressure sensor, up to 30 days	20	27	$26
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	117	168	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	26	1,020	$786,763
Jardiance	Empagliflozin	62	3,746	$71,030
Entresto	Sacubitril/Valsartan	68	3,120	$65,862
Farxiga	Dapagliflozin Propanediol	56	3,330	$59,088
Eliquis	Apixaban	58	2,311	$46,249

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$699	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Elvira Usinowicz, APN, C.?

Tedicare shows public-source Medicare data for Elvira Usinowicz, APN, C. (NPI 1427328277), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elvira Usinowicz, APN, C. have ACO affiliation data?

Elvira Usinowicz, APN, C. is shown with ACO affiliation data for ColigoCare, LLC (MSSP, ACO ID A3591).

What billing organization is linked to Elvira Usinowicz, APN, C.?

Elvira Usinowicz, APN, C. is linked to VALLEY PHYSICIAN SERVICES PC (billing NPI 1467815928) in the available physician profile data.

Does Elvira Usinowicz, APN, C. have Open Payments data?

Elvira Usinowicz, APN, C. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.